Filgrastim biosimilar (Nanogen)

非格司亭生物类似药（Nanogen）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameFilgrastim biosimilar (Nanogen)

Drug Alias NamerhG-CSF (Nanogen)重组人粒细胞刺激因子（Nanogen）非格司亭生物仿制药（Nanogen）Recombinant human G-CSF (Nanogen)Recombinant human granulocyte macrophage colony stimulating factor (Nanogen) +[6]

ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar

Mechanisms of ActionColony stimulating factor 3 receptor agonists

TargetsColony stimulating factor 3 receptor

Therapy Area/IndicationsNeutropenia

Global Approved IndicationsNeutropenia

Approved Indications in ChinaN/A

Original Approved Country/TerritoryVietnam

Original Approved Date2014/01/01

Country/TerritoryVietnam

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesNanogen Biopharmaceutical Co

China Registration ClassN/A

Develop Information

Active CompaniesNanogen Biopharmaceutical Co

Inactive CompaniesN/A

Active IndicationsNeutropenia

Inactive IndicationsN/A

Other Information

ATC CodeL03AA02